China

George Clinical’s largest hub outside the head office of Sydney, offering full CRO services and a site network that spans the country.

George Clinical in China

China is George Clinical’s largest hub outside the head office of Sydney, offering full CRO services and a site network that spans the country.

With its immense potential for patient recruitment and a rapidly growing pharmaceutical market, China, currently the third largest in the world, is an obvious choice for many when entering the Asian market.

The Chinese healthcare delivery system consists of public hospitals and community healthcare centers, with an increasing private care system. Only GCP accredited sites are eligible for running commercial Phase I, II and III studies, and this accreditation can only be achieved by public hospitals in China. The accreditation is issued by the CFDA and NHPFC based upon a site inspection. Accreditation is renewed every 3 years, with a quality review performed by the PFDA every year.

George Clinical has an extensive network of over 260 trial centers in 50 cities for Phase II-IV trials, and a wider network that includes community health centers in semi-urban and rural areas for Phase IV trials.

What are the benefits of conducting clinical trials in China?

  • China has access to a large patient pool
  • Rapidly developing medical infrastructure in urban centres and centres of excellence for many common diseases such as hypertension, diabetes and renal disease
  • Low operational costs

What are the prevalent diseases in China?

  1. Stroke
  2. Ischaemic Heart Disease
  3. Chronic obstructive pulmonary disease
  4. Cancer
  5. Road injury
  6. Hypertension
  7. Diabetes mellitus
  8. Lower respiratory infections

George Clinical China News

全球多重病症的管理势在必行

一份来自英国医学科学院的最新报告显示,由于对多重病症的治疗不足,全球越来越多的人正在遭受终生残疾和早卒。

Global burden of multiple serious illnesses must be urgently addressed

Increasing numbers of people worldwide are suffering life-long disability and dying prematurely due to the ineffective treatment of people with multiple health conditions, a new report suggests. 

《柳叶刀》软饮料、酒精和烟草税是对慢性病发病率上升的有力应对

• 脑卒中、心脏病、糖尿病、慢性呼吸道疾病和癌症等非传染性疾病 (NCDs) 是全球贫困的主要因素 • 与较高收入家庭相比,贫困和未参保家庭更可能招致 NCDs 带来的巨额医疗保健费用,更可能放弃对慢性健康问题的护理 • 对不健康产品征税可以为社会上的贫困人群带来重大的健康收益,特别是如果税收被用于资助有利于穷人的项目 • 预防和治疗 NCDs 与 17 项可持续发展目标中的半数以上息息相关,这对实现 2030 多个目标至关重要

Taxes on soft drinks, alcohol and tobacco are a powerful response to rising rates of chronic diseases

Taxes on soft drinks, alcohol and tobacco are a powerful response to rising rates of non-communicable diseases (NCDs) worldwide, according to the most comprehensive analysis to date of evidence on expenditure, behaviour and socio-economic status, published today...

让智慧陪伴你和宝宝最美的1000天

从母亲怀孕到宝宝两岁生日的1000天,被称为“黄金1000天”,是塑造宝宝健康和成功未来的关键时期,凝聚了母亲无私的爱和奉献。然而,在备孕、怀孕和育儿阶段,孕产妇和妈妈们常常面临诸多问题,比如排队挂号、按时产检,母乳喂养、辅食添加、新生儿照护等等。为了促进孕产妇与医疗保健服务线上线下无缝对接、助力孕产育疑难困惑的解决,在中国儿童少年基金会和高通无线关爱计划的支持下,乔治全球健康研究院(中国)开发了“1000天”App 并即将在石家庄市鹿泉去妇幼保健院率先上线。

Let wisdom accompany you and your baby's most beautiful 1000 DAYS

The 1000 days from pregnancy to the baby's second birthday, is known as the Golden 1000 Days, which is key to shaping baby’s health and success in the future.  However, the busy activities of antenatal examinations, vaccination, and breastfeeding, can be very ch...

Contact

George Clinical Address:
Level 18, Tower B, Horizon Tower
Haidian District
Beijing, 100088
P.R. China

2223, 22/F Tomson Commercial Building,
710 Dongfang Road, Pudong District
Shanghai, 200122
P.R. China

Details

Number of Personnel: 50
In-country Services:

Beijing
Project Management, Clinical Operations, Data Management, Medical and Safety Services, Clinical Compliance, Regulatory Services, Statistics, Health Economics

Shanghai
Clinical Operations

Chengdu
Clinical Operations

Harbin
Project Management, Clinical Operations

Population: 1.4 billion
Official Language: Putonghua (Mandarin). Local dialects may be used
Hospital Records Language: Simplified Chinese
Electronic Hospital Records: Currently, paper records are used.

Twitter Facebook LinkedIn